Synapse Open Synapse
Science

Moderna mRNA vaccine almost halves the risk of skin cancer returning

Nature News · · 2 min read

Long-awaited results from phase III trial show huge benefits for treatment-resistant melanoma.

Same story elsewhere

Latest from Nature News